DANESI, ROMANO
DANESI, ROMANO
Dipartimento di Oncologia ed Emato-Oncologia
Therapeutic drug monitoring of antimicrobials in a paediatric setting: A retrospective single‐centre study
2026 G. Gazzaniga, S. Agliardi, R. Giossi, A. Schianchi, A. Romandini, T. Virdis, S. Nerini Molteni, M.L. De Angelis, S. Paccagnini, C. Gechtman, A. Proto, M. Fossati, S. Oliveri, G.A. Pattarino, E. Altieri, A. Graziosi, A. Pani, R. Danesi, S. Martinelli, C. De Giacomo, F. Scaglione
Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients
2025 M. Ruglioni, I. Petrini, S. Crucitta, A. Sbrana, G.I. Luculli, L. Sadeghi Gol, C. Forte, A. Chella, C. Rolfo, R. Danesi, M. Del Re
The Role of CPX-351 in the Acute Myeloid Leukemia Treatment Landscape: Mechanism of Action, Efficacy, and Safety
2025 L. Pagano, R. Danesi, E. Benedetti, R. Morgagni, L. Romani, A. Venditti
Immunocytokines in cancer treatment: A systematic review
2025 S. Agliardi, C. Veronese, F. Panzeri, S. Palazzini, G. Guarnieri, S. Loiacono, V. Martinelli, A.M. Potenza, E. Sbraga, E. Rissotto, E. Inglese, F. Tosi, F. Villa, G. Patelli, L. Monti, A. Pani, R. Danesi, D. Fornasari, S. Siena, A. Sartore-Bianchi
Artificial intelligence and precision medicine: a pilot study predicting optimal ceftaroline dosage for pediatric patients
2025 M. Frasca, G. Gazzaniga, A. Graziosi, V. De Nicolo, C. De Giacomo, S. Martinelli, M. Senatore, A. Romandini, C. Moretti, G.A.C. Pattarino, A. Proto, R. Danesi, F. Scaglione, G. Vago, D. La Torre, A. Pani
Pharmacokinetic interactions and clinical implications of PPIs and CDKIs in breast cancer: a systematic review and meta-analysis
2025 A. Graziosi, R. Pane, E. Tinazzo, M. Basso, M. Avantaggiato, A. Schianchi, M. Canella, M. Melis, A. Nani, M. Del Re, R. Danesi, A. Pani, R. Giossi, D. Fornasari
Targeting HER2 in breast cancer with brain metastases: A pharmacological point of view with special focus on the permeability of blood-brain barrier to targeted treatments
2024 G. Guglielmi, C. Zamagni, M. Del Re, R. Danesi, S. Fogli
Cost-Effectiveness of Treatment Optimisation with Biomarkers for Immunotherapy in Solid Tumours: A Systematic Review
2024 S. Mucherino, V. Lorenzoni, I. Triulzi, M. Del Re, V. Orlando, A. Capuano, R. Danesi, G. Turchetti, E. Menditto
Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated acute myeloid leukemia to guide treatment strategy
2024 M. Ruglioni, S. Crucitta, G. Irene Luculli, G. Tancredi, M. Livia Del Giudice, S. Mechelli, S. Galimberti, R. Danesi, M. Del Re
Opioid metabolism and drug-drug interaction in cancer
2024 M. Aapro, S. Fogli, B. Morlion, R. Danesi
Concomitant Administration of VEGFR Tyrosine Kinase and Proton Pump Inhibitors May Impair Clinical Outcome of Patients With Metastatic Renal Cancer
2024 M. Del Re, S. Crucitta, N. Brighi, S. Kinspergher, C. Mercinelli, M. Rizzo, V. Conteduca, S. Elena Rebuzzi, T. Beninato, G. Venturi, L. Doni, E. Verzoni, S. Puglisi, M. Landriscina, C. Porta, F. Manfredi, O. Caffo, U. De Giorgi, S. Fogli, R. Danesi
Breaking barriers in triple negative breast cancer (TNBC) – Unleashing the power of antibody-drug conjugates (ADCs)
2024 A. Dri, G. Arpino, G. Bianchini, G. Curigliano, R. Danesi, M. De Laurentiis, L. Del Mastro, A. Fabi, D. Generali, A. Gennari, V. Guarneri, D. Santini, E. Simoncini, C. Zamagni, F. Puglisi
IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients
2024 S. Crucitta, F. Pasqualetti, A. Gonnelli, M. Ruglioni, G.I. Luculli, M. Cantarella, V. Ortenzi, C. Scatena, F. Paiar, A.G. Naccarato, R. Danesi, M. Del Re
Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression
2024 M. Del Re, G.I. Luculli, I. Petrini, A. Sbrana, V. Scotti, D.D.M. Perez, L. Livi, S. Crucitta, M. Iannopollo, F. Mazzoni, M. Ruglioni, C. Tibaldi, E. Olmetto, I. Stasi, E. Baldini, G. Allegrini, L. Antonuzzo, F. Morelli, A. Pierini, N. Panzeri, S. Fogli, A. Chella, C. Rolfo, R. Danesi
Pharmacological insights on novel oral selective estrogen receptor degraders in breast cancer
2024 G. Guglielmi, M. Del Re, L. Sadeghi Gol, C. Bengala, R. Danesi, S. Fogli
Expression of Circulating let-7e and miR-126 May Predict Clinical Remission in Patients With Crohn's Disease Treated With Anti-TNF-α Biologics
2024 G. Guglielmi, S. Crucitta, L. Bertani, M. Ruglioni, G.B. Svizzero, L. Ceccarelli, M. Del Re, R. Danesi, F. Costa, S. Fogli
Epigenetic patterns, accelerated biological aging, and enhanced epigenetic drift detected 6 months following COVID-19 infection: insights from a genome-wide DNA methylation study
2024 L. Calzari, D.F. Dragani, L. Zanotti, E. Inglese, R. Danesi, R. Cavagnola, A. Brusati, F. Ranucci, A.M. Di Blasio, L. Persani, I. Campi, S. De Martino, A. Farsetti, V. Barbi, M. Gottardi Zamperla, G.N. Baldrighi, C. Gaetano, G. Parati, D. Gentilini
TGF-β mRNA levels in circulating extracellular vesicles are associated with response to anti-PD1 treatment in metastatic melanoma
2024 S. Crucitta, F. Cucchiara, R. Marconcini, A. Bulleri, S. Manacorda, A. Capuano, D. Cioni, A. Nuzzo, E. de Jonge, R.H.J. Mathjissen, E. Neri, R.H.N. van Schaik, S. Fogli, R. Danesi, M. Del Re
Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review
2024 F. Martorana, M.V. Sanò, M.R. Valerio, S. Fogli, P. Vigneri, R. Danesi, V. Gebbia
Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group
2024 M.C. Zatelli, A. Faggiano, A. Argentiero, R. Danesi, S. D'Oronzo, S. Fogli, T. Franchina, F. Giorgino, N. Marrano, D. Giuffrida, S. Gori, G. Marino, R. Mazzilli, M. Monami, M. Montagnani, L. Morviducci, A. Natalicchio, A. Ragni, V. Renzelli, A. Russo, L. Sciacca, E. Tuveri, G. Aimaretti, A. Avogaro, R. Candido, M. Di Maio, N. Silvestris, M. Gallo